336 filings
DEF 14A
IMUX
Immunic Inc
Definitive proxy
23 Apr 24
4:48pm
8-K
IMUX
Immunic Inc
8 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:05pm
S-3/A
IMUX
Immunic Inc
Shelf registration (amended)
1 Mar 24
4:09pm
10-K
2023 FY
IMUX
Immunic Inc
Annual report
22 Feb 24
6:38am
8-K
IMUX
Immunic Inc
22 Feb 24
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
6:35am
PRE 14A
uo7 jvl7g
24 Jan 24
Preliminary proxy
5:05pm
D
7n0t5rn3yk42
19 Jan 24
Exempt offering of security
4:05pm
8-K
g2vnu0vnvx
5 Jan 24
Immunic, Inc. Announces Private Placement of up to $240 Million
6:41am
8-K
y8y5b stqlmv5zrn
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
9gaenr8
14 Nov 23
Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:38am
8-K
it7 47pibqiha
18 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
ezfi4gscqk6avi
10 Oct 23
Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
8:48am
S-8
d6m0 ye9j
21 Aug 23
Registration of securities for employees
6:30am
8-K
3rao4uli xi
3 Aug 23
Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:44am
8-K
bm0bckv
30 Jun 23
Submission of Matters to a Vote of Security Holders
8:31am